Bruce Moran, PhD.

Cancer Genomics and Bioinformatics

Research Interests

Immunology
Immunology and Allergy
Cancer Research
Oncology
Paleontology
Space and Planetary Science
Ecology, Evolution, Behavior and Systematics
Molecular Biology

About

Human, functional, GSOH.

Publications

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function

Journal of Experimental Medicine / Feb 01, 2022

Dyck, L., Prendeville, H., Raverdeau, M., Wilk, M. M., Loftus, R. M., Douglas, A., McCormack, J., Moran, B., Wilkinson, M., Mills, E. L., Doughty, M., Fabre, A., Heneghan, H., LeRoux, C., Hogan, A., Chouchani, E. T., O’Shea, D., Brennan, D., & Lynch, L. (2022). Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function. Journal of Experimental Medicine, 219(3). https://doi.org/10.1084/jem.20210042

A Functional Genomic Screen Identifies the Deubiquitinase USP11 as a Novel Transcriptional Regulator of ERα in Breast Cancer

Cancer Research / Nov 13, 2020

Dwane, L., O’Connor, A. E., Das, S., Moran, B., Mulrane, L., Pinto-Fernandez, A., Ward, E., Blümel, A. M., Cavanagh, B. L., Mooney, B., Dirac, A. M., Jirström, K., Kessler, B. M., Ní Chonghaile, T., Bernards, R., Gallagher, W. M., & O’Connor, D. P. (2020). A Functional Genomic Screen Identifies the Deubiquitinase USP11 as a Novel Transcriptional Regulator of ERα in Breast Cancer. Cancer Research, 80(22), 5076–5088. https://doi.org/10.1158/0008-5472.can-20-0214

The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology

Life / Sep 10, 2020

Wilkinson, M., Sinclair, P., Dellatorre-Teixeira, L., Swan, P., Brennan, E., Moran, B., Wedekind, D., Downey, P., Sheahan, K., Conroy, E., Gallagher, W. M., Docherty, N., Roux, C. le, & Brennan, D. J. (2020). The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology. Life, 10(9), 188. https://doi.org/10.3390/life10090188

Evaluating liquid biopsies for methylomic profiling of prostate cancer

Epigenetics / Jan 31, 2020

Silva, R., Moran, B., Russell, N. M., Fahey, C., Vlajnic, T., Manecksha, R. P., Finn, S. P., Brennan, D. J., Gallagher, W. M., & Perry, A. S. (2020). Evaluating liquid biopsies for methylomic profiling of prostate cancer. Epigenetics, 15(6–7), 715–727. https://doi.org/10.1080/15592294.2020.1712876

Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer

Scientific Reports / Jun 17, 2020

Barat, A., Smeets, D., Moran, B., Zhang, W., Cao, S., Das, S., Klinger, R., Betge, J., Murphy, V., Bacon, O., Kay, E. W., Van Grieken, N. C. T., Verheul, H. M. W., Gaiser, T., Schulte, N., Ebert, M. P., Fender, B., Hennessy, B. T., McNamara, D. A., … Prehn, J. H. M. (2020). Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-65869-2

BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

Clinical Cancer Research / Dec 01, 2019

Walsh, L., Haley, K. E., Moran, B., Mooney, B., Tarrant, F., Madden, S. F., Di Grande, A., Fan, Y., Das, S., Rueda, O. M., Dowling, C. M., Varešlija, D., Chin, S.-F., Linn, S., Young, L. S., Jirström, K., Crown, J. P., Bernards, R., Caldas, C., … Ní Chonghaile, T. (2019). BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer. Clinical Cancer Research, 25(23), 7139–7150. https://doi.org/10.1158/1078-0432.ccr-19-0713

PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer

Cancer Research / May 15, 2019

Cox, O. T., Edmunds, S. J., Simon-Keller, K., Li, B., Moran, B., Buckley, N. E., Bustamante-Garrido, M., Healy, N., O’Flanagan, C. H., Gallagher, W. M., Kennedy, R. D., Bernards, R., Caldas, C., Chin, S.-F., Marx, A., & O’Connor, R. (2019). PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer. Cancer Research, 79(10), 2619–2633. https://doi.org/10.1158/0008-5472.can-18-2787

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy

Nature Communications / Oct 05, 2018

Smeets, D., Miller, I. S., O’Connor, D. P., Das, S., Moran, B., Boeckx, B., Gaiser, T., Betge, J., Barat, A., Klinger, R., van Grieken, N. C. T., Cremolini, C., Prenen, H., Mazzone, M., Depreeuw, J., Bacon, O., Fender, B., Brady, J., Hennessy, B. T., … Byrne, A. T. (2018). Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-06567-6

Fam60a defines a variant Sin3a‐Hdac complex in embryonic stem cells required for self‐renewal

The EMBO Journal / May 29, 2017

Streubel, G., Fitzpatrick, D. J., Oliviero, G., Scelfo, A., Moran, B., Das, S., Munawar, N., Watson, A., Wynne, K., Negri, G. L., Dillon, E. T., Jammula, S., Hokamp, K., O’Connor, D. P., Pasini, D., Cagney, G., & Bracken, A. P. (2017). Fam60a defines a variant Sin3a‐Hdac complex in embryonic stem cells required for self‐renewal. The EMBO Journal, 36(15), 2216–2232. Portico. https://doi.org/10.15252/embj.201696307

Experience

University College Dublin

Postdoc / November, 2014June, 2017

Cancer genomics and bioinformatics in large consortia

Oncomark Ltd.

Marie Curie Fellow / July, 2017December, 2018

Bioinformatics on open data to validate clinical decision-making tools

St. Vincent's University Hospital

Bioinformatics Specialist / December, 2018Present

Cancer diagnostic testing and clinical research

Join Bruce M on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts